




Searching News Database: bone regeneration
HSMN NewsFeed - 20 Apr 2017
DePuy Synthes Acquires Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects
DePuy Synthes Acquires Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects
HSMN NewsFeed - 16 Dec 2016
Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement
Antibe Therapeutics Raises $2.4 Million in First Tranche of Private Placement
HSMN NewsFeed - 19 Oct 2016
CollPlant Receives CE Mark for Vergenix(TM)STR for Treatment of Tendinopathy
CollPlant Receives CE Mark for Vergenix(TM)STR for Treatment of Tendinopathy
HSMN NewsFeed - 5 Aug 2015
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
HSMN NewsFeed - 16 Jul 2013
Bacterin’s OsteoSelect(R) DBM Putty Approved for Spinal Fusion Applications
Bacterin’s OsteoSelect(R) DBM Putty Approved for Spinal Fusion Applications
HSMN NewsFeed - 19 Mar 2013
BioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
BioElectronics Announces Chronic and Postoperative Wound Care Product Distribution in Italy
HSMN NewsFeed - 23 Oct 2012
K2M to Showcase Comprehensive Portfolio at 2012 North American Spine Society Annual Meeting
K2M to Showcase Comprehensive Portfolio at 2012 North American Spine Society Annual Meeting
HSMN NewsFeed - 10 Jul 2012
K2M Launches Expanded Biologics Portfolio Featuring VESUVIUS(TM) Osteobiologic & VIKOS(R) Allograft Systems
K2M Launches Expanded Biologics Portfolio Featuring VESUVIUS(TM) Osteobiologic & VIKOS(R) Allograft Systems
HSMN NewsFeed - 3 Mar 2011
BoneGrafix Moves Forward with Development of Next Generation Bone Repair Products
BoneGrafix Moves Forward with Development of Next Generation Bone Repair Products
HSMN NewsFeed - 7 Dec 2010
Orthovita Receives FDA Clearance for Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute
Orthovita Receives FDA Clearance for Vitoss(TM) Bioactive Foam-2X Bone Graft Substitute
HSMN NewsFeed - 9 Mar 2010
Integra LifeSciences Launches Portfolio of Advanced Orthobiologics for Spine Surgery
Integra LifeSciences Launches Portfolio of Advanced Orthobiologics for Spine Surgery
HSMN NewsFeed - 14 Oct 2008
Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
Pioneer(R) Surgical Technology Announces Market Release of FortrOss(TM), a Next Generation Bone Void Filler
HSMN NewsFeed - 16 Sep 2008
Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron Products
HSMN NewsFeed - 29 Apr 2008
Medtronic Receives Approval to Market Smaller Kit Sizes of INFUSE(R) Bone Graft
Medtronic Receives Approval to Market Smaller Kit Sizes of INFUSE(R) Bone Graft
HSMN NewsFeed - 29 Apr 2008
Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
HSMN NewsFeed - 18 Oct 2007
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
HSMN NewsFeed - 27 Jun 2007
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
First Patient Treated in Aastrom Adult Stem Cell Trial for Critical Limb Ischemia
HSMN NewsFeed - 7 May 2007
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
FDA Approves Aastrom Phase III IND for Treatment of Osteonecrosis of the Femoral Head
HSMN NewsFeed - 30 Apr 2007
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
Aastrom Initiates Adult Stem Cell Clinical Trial for Peripheral Arterial Disease
HSMN NewsFeed - 16 Mar 2007
Tutogen Medical Names David C. Greenspan, Ph.D Vice President Global Research & Development
Tutogen Medical Names David C. Greenspan, Ph.D Vice President Global Research & Development
HSMN NewsFeed - 1 Feb 2007
Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
Aastrom Receives Orphan Drug Designation from FDA for Dilated Cardiomyopathy
HSMN NewsFeed - 25 Jan 2007
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS(R)1 to Treat Distal Radius Fractures
HSMN NewsFeed - 17 Jan 2007
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
HSMN NewsFeed - 14 Dec 2006
Sheldon A. Schaffer, Ph.D. Joins Aastrom as Vice President, Corporate Development & Intellectual Property
Sheldon A. Schaffer, Ph.D. Joins Aastrom as Vice President, Corporate Development & Intellectual Property
HSMN NewsFeed - 13 Dec 2006
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
BioMimetic Therapeutics Announces Positive Results Using GEM OS1(TM) Bone Graft in Foot/Ankle Fusions
HSMN NewsFeed - 16 Oct 2006
Ronnda L. Bartel, Ph.D. Joins Aastrom Biosciences as Vice President Research & Development
Ronnda L. Bartel, Ph.D. Joins Aastrom Biosciences as Vice President Research & Development
HSMN NewsFeed - 6 Jul 2006
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
Ortec Issues Update on Its Three Technology Platforms for Regenerative Medicine and Stem Cells
Additional items found! 32

Members Archive contains
32 additional stories matching:
bone regeneration
(Password required)
bone regeneration
(Password required)